Announcement on the waiver of the preemptive right of equity of subsidiaries
Release time:
2020-08-05
证券代码:600668 证券简称:尖峰集团 公告编号:2019-030
债券简称:13尖峰02 债券代码:122344
浙江尖峰集团股份有限公司
关于放弃子公司股权优先购买权的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
l 简要内容:近日,浙江尖峰集团股份有限公司(以下简称“本公司”)与本公司控股子公司浙江尖峰水泥有限公司(以下简称“尖峰水泥”)收到中国建材股份有限公司(以下简称“中建股份”)《通知书》,中建股份拟将其所持有的本公司控股子公司大冶尖峰水泥有限公司(以下简称“大冶尖峰”)24%股权划转给其全资子公司中建材投资有限公司(以下简称“中建投资”),以增加中建投资的注册资本。本次划转以经审计的大冶尖峰2019年5月31日的所有者权益账面值为依据作价11,032.82万元。划转后中建投资将持有大冶尖峰24%的股权。本公司同意上述股权划转事宜并放弃该部分股权的优先购买权。
l 本事项不构成关联交易
l 本事项不构成重大资产重组
l 本事项需经公司董事会审议,不需提交股东大会审议批准。
一、 基本概述
(一)近日,本公司与本公司控股子公司尖峰水泥收到中建股份《通知书》,中建股份拟将其所持有的本公司控股子公司大冶尖峰24%股权划转给其全资子公司中建投资,以增加中建投资的注册资本。本次划转以经审计的大冶尖峰2019年5月31日的所有者权益账面值为依据作价11,032.82万元。划转后中建投资将持有大冶尖峰24%的股权。
中建投资系中建股份的全资子公司,本次大冶尖峰股权变动是中建股份的内部股权划转,划转后该部分股权的实际控制权不变。本公司同意上述划转事宜并放弃该部分股权的优先购买权。该事宜不构成关联交易,也不构成重大资产重组。
(二)董事会审议情况
2019年8月29日,公司以通讯方式召开了第十届董事会第11次会议,公司现有八名董事,全部参加了会议,经审议与表决,董事会以8票同意、0票反对、0票弃权审议并通过了该事项。
(三)根据上海证券交易所《股票上市规则》和公司《章程》等有关规定,该事项属董事会权限范围,无需提交股东大会审议。
二、 标的公司的基本情况
(一)基本情况
1、企业名称:大冶尖峰水泥有限公司
2、企业类型:其他有限责任公司
3、注册地:湖北省大冶市保安镇
4、注册日期:2003年12月24日
5、主要办公地点:湖北省大冶市保安镇
6、法定代表人:蒋晓萌
7、注册资本:25000万元
8、经营范围:水泥、水泥熟料、水泥机电设备制造及销售,建材产品销售,水泥配料用石灰石、砂页岩开采及销售,水泥炉窑固体废物、危险废物协同处置。(涉及许可经营项目,应取得相关部门许可后方可经营)
9、主要股东
|
序号 |
股东姓名 |
出资(万元) |
持股比例(%) |
|
1 |
尖峰水泥 |
17500 |
70.00 |
|
2 |
中建股份 |
6000 |
24.00 |
|
3 |
本公司 |
1500 |
6.00 |
|
合计 |
25000 |
100.00 |
|
注:尖峰水泥是本公司的控股子公司,本公司持有尖峰水泥95.25%的股权。
10、划转前后大冶尖峰股权结构对比

划转前 划转后
(二)大冶尖峰的主要财务数据
单位:万元
|
项目 |
2018.12.31 |
2019.05.31 |
|
总资产 |
71,623.22 |
63,439.15 |
|
总负债 |
19,320.36 |
17,469.08 |
|
所有者权益 |
52,302.86 |
45,970.07 |
|
|
2018年度 |
2019年1-5月 |
|
营业收入 |
94,949.57 |
36,397.38 |
|
利润总额 |
37,358.53 |
14,340.63 |
|
净利润 |
27,901.21 |
10,667.20 |
大冶尖峰2018年度和2019年1-5月的财务数据经具有证券、期货从业资格的天健会计师事务所(特殊普通合伙)审计。
三、 划转各方的基本情况
(一)股权划出方的基本情况
1、企业名称:中国建材股份有限公司
2、企业类型:股份有限公司(上市、国有控股)
3、注册地:北京市海淀区复兴路17号国海广场2号楼(B座)
4、注册日期:1985年06月24日
5、主要办公地点:北京市海淀区复兴路17号国海广场2号楼(B座)
6、法定代表人:曹江林
7、注册资本:843,477.0662万元
8、经营范围:对外派遣与其实力、规模、业绩相适应的境外工程所需的劳务人员;新型建筑材料及制品、新型房屋、水泥及制品、玻璃纤维及制品、复合材料及制品的技术研发、生产和销售;建筑材料的仓储、配送和分销:水泥、玻璃生产线的技术研发、工程设计与工程总承包;新型建筑材料的工程设计与工程总承包;与以上业务相关的技术咨询、信息服务;承包境外建材、建筑和轻纺行业的工程勘测、咨询、设计和监理及工程;进出口业务。( 企业依法自主选择经营项目,开展经营活动;依法须经批准的项目,经相关部门批准后依批准的内容开展经营活动;不得从事木市产业政策禁止和限制类项目的经营活动。)
(二)股权划入方的基本情况
1、企业名称:中建材投资有限公司
2、企业类型:有限责任公司(法人独资)
3、注册地:深圳市罗湖区人民南路国贸大厦12楼南
4、注册日期:2001年01月08日
5、主要办公地点:深圳市罗湖区人民南路国贸大厦12楼南
6、法定代表人:蔡国斌
7、注册资本:300,000万元
8、经营范围:投资兴办实业(具体项目另行申报);从事物流业务(外商投资准入负面清单类除外);电子商务服务(不含增值电信业务);国内贸易;经营进出口业务;在合法取得使用权的土地上从事房地产开发经营(外商投资准入负面清单类除外,具体项目另行申报);物业租赁。(企业经营涉及前置性行政许可的,须取得前置性行政许可文件后方可经营)煤炭经营。
四、 对本公司的影响
中建投资系中建股份的全资子公司,本次划转系中建股份为了进一步优化组织结构、增强中建投资的实力而进行的内部股权划转。本次股权划转后,中建投资将持有大冶尖峰24%的股权,该部分股权的实际控制权不变。本公司与尖峰水泥所持大冶尖峰比例不变,大冶尖峰仍受本公司实际控制,本公司同意放弃该部分股权的优先购买权不存在损害公司及股东特别是中小股东利益的情形。
特此公告
浙江尖峰集团股份有限公司
董事会
二〇一九年八月三十一日
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31